Abstract
Neoadjuvant chemotherapy scheme customized by BRCA1 levels in Her-2 negative primary breast cancer patients: a randomized clinical trial. Bernaq study
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have